false
0000004977
0000004977
2025-08-27
2025-08-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or
15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 27, 2025

Aflac Incorporated
(Exact name of registrant as specified in its
charter)
Georgia |
|
001-07434 |
|
58-1167100 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
1932
Wynnton Road, Columbus, Georgia |
|
31999 |
(Address
of principal executive offices) |
|
(Zip code) |
706.323.3431
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Common Stock, $.10 Par Value |
|
AFL |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 2.03 Creation of a Direct Financial Obligation
or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
On August 27, 2025 (the “Closing Date”), pursuant to the
Purchase Agreement among Aflac Incorporated (the “Company”), TD Securities (USA) LLC, Goldman Sachs & Co. LLC, Mizuho
Securities USA LLC, SMBC Nikko Securities America, Inc. and Wells Fargo Securities, LLC (the “Representatives”), as representatives
of the several initial purchasers named therein, and Wynnton Funding Trust, a Delaware statutory trust (the “2035 Trust”),
the 2035 Trust completed the issuance and sale of 1,000,000 of its Pre-Capitalized Trust Securities redeemable August 15, 2035 (the “2035
P-Caps”) for an aggregate purchase price of $1,000,000,000, as a contingent funding arrangement with a 0.9875%
facility fee per annum that provides the Company the right at any time over a ten-year period to issue and require the 2035 Trust to purchase
up to $1,000,000,000 aggregate principal amount of the Company’s 5.251% Senior Notes due 2035 (the “2035 Senior Notes”),
pursuant to the Facility Agreement, dated the Closing Date (the “2035 Facility Agreement”), among the Company, the 2035 Trust
and The Bank of New York Mellon Trust Company, N.A., as notes trustee for the 2035 Senior Notes.
Also, on the Closing Date, pursuant to the Purchase Agreement among
the Company, the Representatives, as representatives of the several initial purchasers named therein, and Wynnton Funding Trust II, a
Delaware statutory trust (the “2055 Trust” and, the 2035 Trust and 2055 Trust, each a “Trust”), the 2055 Trust
completed the issuance and sale of 1,000,000 of its Pre-Capitalized Trust Securities redeemable August 15, 2055 (the “2055 P-Caps”
and, together with the 2035 P-Caps, the “P-Caps”) for an aggregate purchase price of $1,000,000,000, as a contingent funding
arrangement with a 1.1218% facility fee per annum that provides the Company the right at any time
over a thirty-year period to issue and require the 2055 Trust to purchase up to $1,000,000,000 aggregate principal amount of the Company’s
5.991% Senior Notes due 2055 (the “2055 Senior Notes” and, together with the 2035 Senior Notes, the “Senior Notes”),
pursuant to the Facility Agreement, dated the Closing Date (the “2055 Facility Agreement” and, the 2035 Facility Agreement
and the 2055 Facility Agreement, each a “Facility Agreement”), among the Company, the 2055 Trust and The Bank of New York
Mellon Trust Company, N.A., as notes trustee for the 2055 Senior Notes.
The P-Caps do not carry registration rights and may be held only by
qualified institutional buyers, as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”),
that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended (the
“Investment Company Act”). The issuances and sales of the P-Caps were completed as private placements pursuant to Rule 144A
under the Securities Act. Each Trust invested the proceeds from the sale of P-Caps in a portfolio of principal and/or interest strips
of U.S. Treasury securities (the “Eligible Assets”). The following describes the terms of each Facility Agreement, which in
each case apply in respect of the respective Trust, P-Caps, Senior Notes, facility fee and maturity date.
Each Facility Agreement provides that the applicable Trust grants the
Company the right to require the Trust to purchase, on one or more occasions, an aggregate principal amount at any one time outstanding
and held by the Trust, of up to a maximum amount of the applicable Senior Notes (each an “Issuance Right”). The Company has
agreed to pay to the Trust a semi-annual facility fee calculated at a fixed rate per annum, applied to the unexercised portion of the
applicable Issuance Right. The Company may direct the Trust to grant the right to exercise the Issuance Right with respect to all or a
designated amount of the Senior Notes to one or more assignees (who are consolidated subsidiaries of the Company or persons to whom the
Company has an obligation) (each an “Issuance Right Assignee”), who may cause the Senior Notes to be issued to the Trust and
receive the corresponding portion of Eligible Assets that would otherwise have been delivered to the Company pursuant to the exercise
of such Issuance Right. On the Closing Date, the Company also entered into a trust expense reimbursement agreement with each Trust, pursuant
to which the Company agreed to reimburse the Trust for its expenses in connection with the transaction, including trustees’ fees.
The applicable Issuance Right will be exercised automatically in full
if (1) the Company fails to pay the applicable facility fee when due under the applicable Facility Agreement or any amount due and owing
under the applicable trust expense reimbursement agreement on any distribution date or fails on any distribution date to purchase and
pay for any Eligible Assets that are due and unpaid on such distribution date and are required to be purchased at their face amount from
the applicable Trust pursuant to the terms of the Facility Agreement and such failure is not cured (including payment in full of the special
facility fee due as a result of such failure) within 30 days, or (2) upon certain bankruptcy events involving the Company. The Company
will be required to exercise the Issuance Right in full if (1) it reasonably believes that its consolidated net worth, determined in accordance
with U.S. GAAP, but excluding accumulated other comprehensive income (or loss) and equity of non-controlling interests attributable thereto,
has fallen below $10 billion, which amount may be adjusted from time to time upon the occurrence of certain specified events, (2) an event
of default under the indenture that governs the applicable Senior Notes has occurred or would have occurred had the Senior Notes been
outstanding, or (3)(A) certain events relating to the Trust’s status as an “investment company” under the Investment
Company Act, are reasonably likely to occur or have occurred and (B)(x) within five business days of such determination, the transaction
agreements have not been amended to prevent or cease such event or (y) the Company has reasonably determined that no such amendment is
possible. In addition, at any time following exercise of the Issuance Right in whole or in part, other than upon an automatic exercise
or a required exercise as described in this paragraph, the Company will have the right to repurchase any or all of the Senior Notes then
held by the Trust in exchange for Eligible Assets that entitle the Trust to receive payments of principal and interest in the same amounts
as the Trust would have received on the Eligible Assets that it delivered to the Company or any Issuance Right Assignee upon the exercise
of the Issuance Right in respect of the Senior Notes to be so repurchased.
The Company has the right to redeem, at its option, the applicable
Senior Notes issued to the applicable Trust at any time in whole or in part and, in lieu of issuing and selling Senior Notes to the Trust
pursuant to any voluntary exercise of the applicable Issuance Right, may elect to deliver a cash amount equal to the redemption price
of the Senior Notes in exchange for a corresponding portion of Eligible Assets. The redemption price of the Senior Notes being redeemed
will equal the greater of the principal amount of such Senior Notes or a make-whole redemption price, in each case plus accrued and unpaid
interest to, but excluding, the date of redemption. The Trust will apply the redemption proceeds and such payments to redeem P-Caps having
an initial purchase price equal to the principal amount of such Senior Notes on the redemption or payment date. The P-Caps will be redeemed
on the maturity date or earlier upon an early redemption of the applicable Senior Notes. The Trust will terminate upon the redemption
of all its outstanding P-Caps or the earlier occurrence of certain other events.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Aflac Incorporated |
|
|
August 27, 2025 |
/s/ Robin L. Blackmon |
|
(Robin L. Blackmon) |
|
Senior Vice President, Financial Services |
|
Chief Accounting Officer |